Low FAS/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation

Journal of Investigative Dermatology

Volumn 129, Issue 5, 2009, Pages 1165-1173

  Wu, Jianqiang ^a   Nihal, Minakshi ^a   Siddiqui, Jawed ^a   Vonderheid, Eric C ^b   Wood, Gary S ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ISOLATION; CELL MEMBRANE RESISTANCE; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMIA CELL LINE; MYCOSIS FUNGOIDES; NUCLEOTIDE SEQUENCE; PARAPSORIASIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DEPLETION; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SENSITIVITY AND SPECIFICITY; SEZARY SYNDROME; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

EID: 65249125807     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.309     Document Type: Article

References (22)

1. Braun FK, Fecker LF, Schwarz C, Walden P, Assaf C, Durkop H et al. (2007) Blockade of death receptor-mediated pathways early in the signaling cascade coincides with distinct apoptosis resistance in cutaneous T-cell lymphoma cells. J Invest Dermatol 127:2425-37
2. Contassot E, Kerl K, Roques S, Shane R, Gaide O, Dupuis M et al. (2008) Resistance to FasL and tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in Sezary syndrome T-cells associated with impaired death receptor and FLICE-inhibitory protein expression. Blood 111:4780-7
3. Debusscher C, Simonart T (2001) Differential expression of Fas in tumourstage mycosis fungoides (MF) and MF-like cutaneous T-cell pseudolymphoma. Br J Dermatol 144:903
4. Dereure O, Levi E, Vonderheid EC, Kadin ME (2002) Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin. J Invest Dermatol 118:949-56
5. Dummer R, Michie SA, Kell D, Gould JW, Haeffner AC, Smoller BR et al. (1995) Expression of bcl-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous T-cell infiltrates. J Cutan Pathol 22:11-7
6. Girardi M, Heald PW, Wilson LD (2004) The pathogenesis of mycosis fungoides. N Engl J Med 350:1978-88
7. Huang DC, Hahne M, Schroeter M, Frei K, Fontana A, Villunger A et al. (1999) Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L). Proc Natl Acad Sci USA 96:14871-6
8. Kuzel TM (2003) Systemic chemotherapy for the treatment of mycosis fungoides and Sézary syndrome. Dermatologie Therapy 16:355-61
9. Lettau M, Qian J, Linkermann A, Latreille M, Larose L, Kabelitz D et al. (2006) The adaptor protein Nck interacts with Fas ligand: guiding the death factor to the cytotoxic immunological synapse. Proc Natl Acad Sci USA 103:5911-6
10. Li XR, Chong AS, Wu J, Roebuck KA, Kumar A, Parrillo JE et al. (1999) Transcriptional regulation of Fas gene expression by GA-binding protein and AP-1 in T cell antigen receptor.CD3 complex-stimulated T cells. J Biol Chem 274:35203-10
11. Marrogi AJ, Khan MA, Vonderheid EC, Wood CS, McBurney E (1999) p53 tumor suppressor gene mutations in transformed cutaneous T-cell lymphoma: a study of 12 cases. J Cutan Pathol 26:369-78
12. Meech SJ, Edelson R, Walsh P, Norris DA, Duke RC (2001) Reversible resistance to apoptosis in cutaneous T cell lymphoma. Ann NY Acad Sci 941:46-58
13. Nevala H, Karenko L, Vakeva L, Ranki A (2001) Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis. Br J Dermatol 145:928-37
14. Ni X, Zhang C, Talpur R, Duvic M (2005) Resistance to activation-induced cell death and bystander cytotoxicity via the Fas/Fas ligand pathway are implicated in the pathogenesis of cutaneous T cell lymphomas. J Invest Dermatol 124:741-50
15. Nielsen M, Kaestel CG, Eriksen KW, Woetmann A, Stokkedal T, Kaltoft K et al. (1999) Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells. Leukemia 13:735-8
16. Nihal M, Wood GS (2007) Anti-proliferative and pro-apoptotic effects of ECCC and ECCC/IFNα in human melanoma and CTCL lines. J Invest Dermatol 127:S50
17. Osel la-Abate S, Zaccagna A, Savoia P, Quaglino P, Salomone B, Bernengo MC (2001) Expression of apoptosis markers on peripheral blood lymphocytes from patients with cutaneous T-cell lymphoma during extracorporeal photochemotherapy. J Am Acad Dermatol 44: 40-7
18. van Doom R, Dijkman R, Vermeer MH, Starink TM, Willemze R, Tensen CP (2002) A novel splice variant of the Fas gene in patients with cutaneous T-cell lymphoma. Cancer Res 62:5389-92
19. Veelken H, Sklar JL, Wood GS (1996) Detection of low-level tumor cells in allergic contact dermatitis induced by mechlorethamine in patients with mycosis fungoides. J Invest Dermatol 106:685-8
20. Wood CM, Goodman PA, Vassilev AO, Uckun FM (2003) CD95 (APO-1/FAS) deficiency in infant acute lymphoblastic leukemia: detection of novel soluble Fas splice variants. Eur J Haematol 70:156-71
21. Wood G (2001) The Benign and Malignant Cutaneous Lymphoproliferative Disorders Including Mycosis Fungoides. Williams and Wilkins: Baltimore MD, 1183-233 pp
22. Zoi-Toli O, Vermeer MH, De Vries E, Van Beek P, Meijer CJ, Willemze R (2000) Expression of Fas and Fas-ligand in primary cutaneous T-cell lymphoma (CTCL): association between lack of Fas expression and aggressive types of CTCL. Br J Dermatol 143:313-9